Imatinib resistance and blast transformation of chronic myeloid leukemia associated with a novel tri-nucleotide insertion mutation of BCR-ABL kinase domain at position K294
A letter to the editor is presented which discusses the introduction of imatinib mesylate (IM) in the medical case of an 18-year old man with in-frame mutations and blast transformation of chronic myeloid leukemia (CML).
Saved in:
Main Authors: | , , , |
---|---|
Format: | Article |
Published: |
Springer Verlag (Germany)
2012
|
Subjects: | |
Online Access: | http://eprints.um.edu.my/12027/ http://link.springer.com/article/10.1007%2Fs00277-011-1215-2 http://dx.doi.org/10.1007/s00277-011-1215-2 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|